Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide

Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide

NEW YORK, Jan 10, 2026, 06:06 EST — Market closed

Oracle shares jumped 4.7% Friday, ending at $198.52 after trading in a range from $188.91 up to $200.13. Buyers drove the stock close to the $200 threshold, a level many traders watch closely as a “line in the sand.” Volume hit roughly 26.2 million shares.

SB Energy announced late Friday that OpenAI and SoftBank are committing $1 billion to boost data-center and power infrastructure for Stargate, a $500 billion project supported by Oracle. The company plans to develop and run a 1.2-gigawatt OpenAI facility in Milam County, Texas. (Reuters)

Oracle’s story now hinges on whether big AI infrastructure deals can translate into steady cloud revenue—and how quickly. The broader market lent support on Friday: the S&P 500 hit a record closing high following a weaker U.S. jobs report. Investors also kept an eye on an upcoming Supreme Court ruling that might shake up the tariff landscape. “Investors are getting granular and picking the winners and losers,” said Zachary Hill, head of portfolio management at Horizon Investments. (Reuters)

Oracle passed a dividend milestone as well. According to a recent filing, the company declared a quarterly cash dividend of 50 cents per share, payable on Jan. 23 to shareholders recorded by Jan. 9. The ex-dividend date marks the first trading day when new buyers won’t receive the upcoming payment. (SEC)

Investors are zeroed in on Oracle’s guidance and how it’s funding its expansion. The company’s latest quarterly report showed heavy capital spending on data centers, with capex hitting roughly $8.1 billion for the quarter ending Nov. 30. Meanwhile, notes payable and borrowings stood at $108.1 billion. Oracle also shared its cloud revenue growth and earnings goals for the fiscal third quarter. (Nasdaq)

The upside scenario still faces hurdles around execution and funding. Back in December, Oracle warned that sales and profit would fall short of expectations, while flagging a $15 billion jump in spending compared to earlier forecasts—highlighting how fast costs are climbing. Then, days later, the company denied reports of OpenAI-related data-center delays. Spokesperson Michael Egbert told Reuters, “There have been no delays to any sites” needed to meet commitments. (Reuters)

Traders are gearing up for Oracle’s upcoming earnings report, expected around March 9, while keeping a close eye on the Federal Reserve’s policy meeting set for Jan. 27-28 for hints on how rate changes might impact tech stocks. The immediate focus, though, is Tuesday, Jan. 13, when the U.S. Labor Department drops the December consumer price index at 8:30 a.m. ET. (Federal Reserve)

Stock Market Today

  • Bayer Share Price Surges 107% in One Year: Is It Still Undervalued?
    February 1, 2026, 8:59 PM EST. Bayer's (XTRA:BAYN) share price soared 106.9% over the past year, closing at €44.56, despite declines over the 3- and 5-year periods. The surge follows ongoing company efforts to restructure and address legal risks, influencing investor sentiment. A Discounted Cash Flow (DCF) model, which estimates intrinsic value by projecting future cash flows, suggests Bayer is undervalued by about 79.5%, placing its fair value around €217.76 per share. The model uses a 2 Stage Free Cash Flow to Equity approach with free cash flow projected to rise to €6.4 billion by 2030. While recent market moves reflect optimism, valuation metrics indicate potential undervaluation, presenting a mixed risk-reward profile amid sector conditions.
NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade
Previous Story

NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test
Next Story

Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test

Go toTop